Related Experiment Video
Updated: Dec 24, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Case series: Fulminant community-acquired Acinetobacter pneumonia
1Sarawak General Hospital, Department of Medical, Infectious Disease Unit, Kuching, Sarawak, Malaysia. tonnii_sia@yahoo.com.
Community-acquired Acinetobacter pneumonia is rare but severe, particularly in individuals with a history of alcohol consumption. Early diagnosis and targeted high-dose sulbactam are crucial for managing this serious infection.
Area of Science:
- Medicine
- Infectious Diseases
- Pulmonology
Background:
- Acinetobacter infections are typically hospital-acquired, with drug-resistant strains posing a significant threat.
- Community-acquired Acinetobacter pneumonia is an infrequent but potentially severe clinical presentation.
Observation:
- Three cases of community-acquired Acinetobacter pneumonia are presented.
- All patients had a history of regular home-brewed alcohol consumption.
- Patients presented with severe acute respiratory distress requiring mechanical ventilation and exhibited leukopenia.
Findings:
- Blood or endotracheal aspirate cultures confirmed Acinetobacter species in all cases.
- The identified Acinetobacter strains were sensitive only to high-dose sulbactam.
- The patients had a high mortality rate, succumbing within 2 to 10 days of admission.
Implications:
- This case series highlights the critical need for early recognition of community-acquired Acinetobacter pneumonia.
- Prompt and appropriate antibiotic therapy, specifically high-dose sulbactam, may improve patient outcomes.
- Further research into risk factors, such as alcohol consumption, and treatment strategies for this rare infection is warranted.
More Related Videos
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis I: Introduction